Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome

被引:46
作者
Christeff, N
Melchior, JC
de Truchis, P
Perronne, C
Gougeon, ML
机构
[1] Inst Pasteur, AIDS & Retroviruses Dept, CNRS, URA 1930, F-75724 Paris, France
[2] Hop Ray Poincare, Serv Malad Infect & Trop, F-92380 Garches, France
[3] CHU Bichat Claude Bernard, Lab Biochim B, F-75877 Paris, France
关键词
ART; HIV-1; hyperlipidaemia; interferon alpha; lipodystrophy;
D O I
10.1046/j.0014-2972.2001.00940.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A syndrome of lipodystrophy (LD) associated with peripheral lipoatrophy and central/visceral adiposity has been reported in HIV-1-infected patients treated by combined antiretroviral therapy (ART). Lipid metabolism is partly regulated by both steroid hormones and cytokines and we have previously reported that dyslipidaemia in LD-positive men is correlated to an increase in cortisol : DHEA ratio (Christeff et al., AIDS 1999;13:2251). In this study we questioned whether it is also related to cytokine perturbations. Materials and Methods A cross-sectional study was performed on 42 HIV-1-positive men on ART, 27 of whom had symptoms of LD, defined by computed tomography scan. Serum cytokines (IFN-alpha, INF-alpha, sTNF-RI, sTNF-RII, IL-6, IL-1beta and IL-2) and lipids [cholesterol, triglycerides (TG) and their subclasses], and apolipoproteins (Apo), were determined. Results Serum IFN-alpha was markedly increased in LD-positive compared with LD-negative men and controls. IL-6 and TNF-alpha concentrations were also significantly elevated in HIV-positive men compared to controls but the levels of these cytokines did not differ between the two groups of patients. A significant positive correlation was found between accumulation of IFN-alpha. and increased levels of cholesterol, TG, VLDL cholesterol, VLDL TG, ApoB and ApoB-ApoA1 ratio. A multivariate forward-performed analysis revealed that IFN-alpha is the best marker for lipid perturbations associated to LD, followed by insulin and cortisol : DHEA ratio. Conclusions This study demonstrates an association between serum IFN-alpha and lipid alterations in LD-positive men. The concomittant action of IFN-alpha and cortisol : DHEA ratio is probably one of the mechanisms responsible for hyperlipidaemia in LD syndrome.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 33 条
[1]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[2]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[3]   Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations [J].
Christeff, N ;
Melchior, JC ;
de Truchis, P ;
Perronne, C ;
Nunez, EA ;
Gougeon, ML .
AIDS, 1999, 13 (16) :2251-2260
[4]  
CHRISTEFF N, 1997, J CLIN PATHOL, V30, P341
[5]   Endocrine and metabolic effects of interferon-alpha in humans [J].
Corssmit, EPM ;
Heijligenberg, R ;
Endert, E ;
Ackermans, MT ;
Sauerwein, HP ;
Romijn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3265-3269
[6]   Activation of human monocytes by LPS and DHEA [J].
Delpedro, AD ;
Barjavel, MJ ;
Mamdouh, Z ;
Bakouche, O .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (02) :125-135
[7]   New-onset diabetes mellitus associated with use of protease inhibitor [J].
Eastone, JA ;
Decker, CF .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :948-948
[8]   MULTIPLE CYTOKINES STIMULATE HEPATIC LIPID-SYNTHESIS INVIVO [J].
FEINGOLD, KR ;
SOUED, M ;
SERIO, MK ;
MOSER, AH ;
DINARELLO, CA ;
GRUNFELD, C .
ENDOCRINOLOGY, 1989, 125 (01) :267-274
[9]  
Gallet B, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(05)78643-8
[10]   INTERFERON-ALPHA STIMULATES THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INVIVO AND INVITRO [J].
GISSLINGER, H ;
SVOBODA, T ;
CLODI, M ;
GILLY, B ;
LUDWIG, H ;
HAVELEC, L ;
LUGER, A .
NEUROENDOCRINOLOGY, 1993, 57 (03) :489-495